| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.13 | 6e-05 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0004 |